Delivery Order SPE2DR25D1201-SPE2DR26FAKCJ
- Not listed
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- The Defense Logistics Agency awarded a delivery order valued at $15,357.37 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,125.90 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with performance in Conshohocken, Pennsylvania and completion targeted for December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a $6,337.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Arimidex 1 mg tablets, with a completion deadline of December 9, 2025. This non-set-aside competitive award reflects AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to federal military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $5,789.34 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,219.00 by the Defense Logistics Agency for 30-count tablets of Arimidex 1 mg. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, was made under firm fixed-price terms with no set-aside designation, indicating the contract was competitively awarded. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $11,611.24 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets under a firm fixed-price contract. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a small-value pharmaceutical procurement with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count unit) under a firm fixed-price contract valued at $1,009.95. The delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $6,458.62 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 count) under a firm fixed-price contract valued at $12,043.27. This non-competitive award, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a delivery order against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKCJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,985.07 to AmerisourceBergen Drug Corp for 30-count packages of Arimidex 1 mg tablets. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of December 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this order at its corporate office location in the same city. The delivery order is a child contract issued against AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, providing comprehensive pharmaceutical procurement support for military and veteran healthcare systems. The parent IDC functions as a global pharmaceutical support vehicle enabling delivery of a broad range of products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support DoD healthcare programs worldwide. This particular delivery order for Arimidex, an aromatase inhibitor used in oncology treatment, exemplifies the company's role in supplying specialized pharmaceutical products to federal healthcare customers including the Defense Health Agency and other government medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 12/11/25 |